References
- Thompson AR, Wood WG, Stamatoyannopoulous G. X-linked syndrome of platelet dysfunction, thrombocytopenia and imbalanced globin chain synthesis with hemolysis. Blood 1977; 50: 303–316
- Pevny L, Simon MC, Robertson E, Klein WH, Tsai SF, D'Agati V, Orkin SH, Costantini F. Erythroid differentiation in chimaeric mice blocked by a targeted mutation in the gene for transcription factor GATA-1. Nature 1931; 349: 257–260
- Weiss MJ, Keller G, Orkin SH. Novel insights into erythroid development revealed through in vitro differentiation of GATA-1 embroyonic stem cells. Genes Dev 1994; 8: 1184–1197
- Nichols KE, Crispino JD, Poncz M, White JG, Orkin SH, Maris JM, Weiss MJ. Familial dyserythropoietic anaemia and thrombocytopenia due to an inherited mutation in GATA1. Nat Genet 2000; 24: 266–270
- Freson K, Devriendt K, Matthijs G, Van Hoof A, De Vos R, Thys C, Minner K, Hoylaerts M, Vermylen J, Van Geet C. Platelet characteristics in patients with X-linked macrothrombocytopenia because of a novel GATA-1 mutation. Blood 2001; 98: 85–92
- Freson K, Matthijs G, Thys C, Marien P, Hoylaerts M, Vermylen J, Van Geet C. Different substitutions at residue D218 of the X-linked transcription factor GATA1 lead to altered clinical severity of macrothrombocytopenia and anemia and are associated with variable skewed X inactivation. Hum Mol Genet 2002; 11: 147–152
- Shivdasani RA, Fujiwara Y, McDevitt MA, Orkin SH. A lineage-selective knockout establishes the critical role of transcription factor of GATA-1 in megakaryocyte growth and platelet development. Embo J 1997; 16: 3965–3973
- Mehaffey MG, Newton EL, Ghandi MJ, Crossley M, Drachman JG. X-linked thrombocytopenia caused by a novel mutation of GATA-1. Blood 2001; 98: 2681–2688
- Vyas P, Ault K, Jackson CW, Orkin SH, Shivdasani RA. Consequences of GATA-1 deficiency in megakaryocytes and platelets. Blood 1999; 93: 2867–2875
- Phillips JD, Steensma DP, Spangrude GJ, Kushner JP. Congenital erythropoietic porphyria, Bthalassemia intermedia and thrombocytopenia due to a GATA-1 mutation. Blood 2005; 106: 15a
- Balduini CL, Pecci A, Loffredo G, Iyyo P, Noris P, Grosso M, Bergamaschi G, Rosti V, Magrini U, Ceresa IF, et al. Effects of the R216 Q mutation of GATA-1 on erythropoiesis and megakaryocytopoiesis. Blood 2004; 91: 129–140
- Tubman VN, Levine JE, Camoagna DR, Fleming MD, Neufeld EJ. X-linked Gray Platelet Syndrome due to a GATA-1 Arg 216 G in mutation. Blood 2005; 106: 6a
- Raccuglia G. Gray platelet syndrome: A variety of qualitative platelet disorders. Am J Med 1971; 51: 818–828
- White JG. Ultrastructural studies of the gray platelet syndrome. Am J Pathol 1979; 95: 445–462
- White JG. Effects of ethylenediamine tetracetic acid (EDTA) on platelet fine structure. Scand J Haematol 1968; 5: 241–254
- White JG. Platelet membrane interactions. Platelets 1999; 10: 368–381
- White JG. The morphology of platelet function. LA Harker, TS Zimmerman. Churchill-Livingstone, New York 1983; 1–25
- Witkop CJ, Krumwiede M, Sedano HO, White JG. The reliability of absent platelet dense bodies as a diagnostic criterion for Hermansky-Pudlak syndrome. Am J Hematol 1987; 26: 305–311
- White JG, Key NS, King RA, Vercellotti GM. The white platelet syndrome: A new autosomal dominant platelet disorder. 1. Structural abnormalities. Platelets 2004; 15: 173–184
- Breton-Gorius J, Vainchenker W, Nurden A, Levy-Toledano S, Caen J. Defective α-granule production in megakaryocytes from gray platelet syndrome. Am J Pathol 1981; 102: 10–19
- White JG. Medich Giant Platelet Disorder: A Unique α-granule deficiency. 1. Structural abnormalities. Platelets 2004; 15: 345–353
- Leven RM, Toblin F. Megakaryocyte and platelet ultrastructure in the Wistar Furth rat. Am J Pathol 1988; 132: 417–426
- Breton-Gorius J, Reyes F. Ultrastructure of human bone marrow cell maturation. Int Rev Cytol 1976; 46: 251–321
- White JG. Platelet morphology. The Circulating Platelet, SE Johnson. Academic Press, New York 1971; 45–121
- White JG. Ultrastructural physiology and cytochemistry of blood platelets. Platelets 1971; 6: 83–115
- Cramer EM, Vainchenker W, Vinci G, Guichard J, Breton-Gorius J. Gray platelet syndrome: Immunoelectron microscope localization of fibrinogen and von Willebrand factor in platelets and megakaryocytes. Blood 1985; 66: 1309–1316
- Risa JP, George JN, Bainton DF, Nurden AT, Caen JP, McEver RP. Gray platelet syndrome: Demonstration of α-granule membranes that can fuse with the cell surface. J Clin Invest 1987; 80: 1138–1146
- White JG, Keel S, Reyes M, Burris SM. Alpha-delta storage pool deficiency in 3 generations. Platelets, (In press)
- White JG. Localization of a lysosomal enzyme in platelets from patients with the white platelets syndrome. Platelets, (In press)
- Radey JM, Haller CJ. The demarcation membrane system of the megakaryocyte: A misnomer?. Blood 1982; 60: 213–219
- Italiano JE, Jr, Lecine P, Shivdasani RA, Hartwig JH. Blood platelets are assembled principally at the ends of proplatelet processes produced by differentiated megakaryocytes. J Cell Biol 1999; 147: 1299–1312
- Schulze H, Karpal M, Hurov J, Kim SW, Zhang J, Cantley WC, Graf T, Shivdasani A. Characterization of the megakaryocyte demarcation membrane system and its role in thrombopoiesis. Blood 2006; 107: 3868–3875
- White JG. Structural defects in inherited and giant platelet disorders. Adv Hum Genet 1990; 19: 133–234
- White JG. Giant platelet disorders. Haemostasiologie 2002; 87: 85–89